0.8079
price down icon0.06%   -0.0005
pre-market  プレマーケット:  .83   0.0221   +2.74%
loading
前日終値:
$0.8084
開ける:
$0.8106
24時間の取引高:
405.47K
Relative Volume:
0.41
時価総額:
$164.98M
収益:
-
当期純損益:
$-274.18M
株価収益率:
-0.3187
EPS:
-2.5346
ネットキャッシュフロー:
$-198.33M
1週間 パフォーマンス:
+3.58%
1か月 パフォーマンス:
+18.86%
6か月 パフォーマンス:
-92.40%
1年 パフォーマンス:
-90.77%
1日の値動き範囲:
Value
$0.784
$0.8328
1週間の範囲:
Value
$0.745
$0.8499
52週間の値動き範囲:
Value
$0.611
$17.19

Neumora Therapeutics Inc Stock (NMRA) Company Profile

Name
名前
Neumora Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
(857) 760-0900
Name
住所
490 ARSENAL WAY, SUITE 200, WATERTOWN
Name
職員
103
Name
Twitter
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
NMRA's Discussions on Twitter

NMRA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NMRA
Neumora Therapeutics Inc
0.8079 164.98M 0 -274.18M -198.33M -2.5346
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.94 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.12 28.51B 3.81B -644.79M -669.77M -6.24

Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 ダウングレード BofA Securities Buy → Underperform
2025-03-10 ダウングレード William Blair Outperform → Mkt Perform
2025-03-07 ダウングレード Guggenheim Buy → Neutral
2025-03-07 ダウングレード Stifel Buy → Hold
2025-01-02 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-11-05 ダウングレード JP Morgan Overweight → Neutral
2024-10-01 開始されました H.C. Wainwright Buy
2024-07-22 開始されました Needham Buy
2024-07-08 開始されました Mizuho Outperform
2023-12-12 開始されました Deutsche Bank Hold
2023-10-10 開始されました BofA Securities Buy
2023-10-10 開始されました Guggenheim Buy
2023-10-10 開始されました JP Morgan Overweight
2023-10-10 開始されました RBC Capital Mkts Outperform
2023-10-10 開始されました Stifel Buy
2023-10-10 開始されました William Blair Outperform
すべてを表示

Neumora Therapeutics Inc (NMRA) 最新ニュース

pulisher
Jun 12, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Acquired by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

72,622 Shares in Neumora Therapeutics, Inc. (NASDAQ:NMRA) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Shareholders Filed a Lawsuit Against Neumora Therapeutics for Misleading Drug Trial Claims - TradingView

Jun 10, 2025
pulisher
Jun 05, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Jun 05, 2025
pulisher
Jun 01, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of “Hold” by Analysts - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Ameriprise Financial Inc. Takes Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Neumora Therapeutics Holds Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Invests $221,000 in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 29, 2025
pulisher
May 28, 2025

Deutsche Bank AG Has $775,000 Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 28, 2025
pulisher
May 27, 2025

Kuehn Law Encourages Investors of Grocery Outlet Holding Corp. to Contact Law Firm - GlobeNewswire Inc.

May 27, 2025
pulisher
May 25, 2025

26,500 Shares in Neumora Therapeutics, Inc. (NASDAQ:NMRA) Bought by Janus Henderson Group PLC - Defense World

May 25, 2025
pulisher
May 22, 2025

Neumora Therapeutics’s SWOT analysis: navigating challenges in neuropsychiatric drug development - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Undervalued Opportunities: 3 Penny Stocks With Market Caps Above $30M - simplywall.st

May 22, 2025
pulisher
May 21, 2025

Softbank Group CORP. Sells 1,005,726 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 21, 2025
pulisher
May 20, 2025

Price T Rowe Associates Inc. MD Cuts Stock Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 20, 2025
pulisher
May 19, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Purchased by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 18, 2025

Orbimed Advisors LLC Has $8.53 Million Stock Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 18, 2025
pulisher
May 18, 2025

Neumora Therapeutics (NASDAQ:NMRA) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

May 18, 2025
pulisher
May 17, 2025

HC Wainwright Has Pessimistic Outlook of NMRA Q2 Earnings - MarketBeat

May 17, 2025
pulisher
May 17, 2025

Neumora Therapeutics faces Nasdaq delisting risk - Investing.com Australia

May 17, 2025
pulisher
May 17, 2025

The Manufacturers Life Insurance Company Has $478,000 Holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 17, 2025
pulisher
May 17, 2025

Neumora Therapeutics (NASDAQ:NMRA) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

May 17, 2025
pulisher
May 16, 2025

Neumora Therapeutics faces Nasdaq delisting risk By Investing.com - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Neumora Therapeutics Faces Nasdaq Non-Compliance Notice - TipRanks

May 16, 2025
pulisher
May 16, 2025

Neumora Therapeutics Inc On May 14, Receives Nasdaq Non-Compliance Notice - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

What is HC Wainwright’s Forecast for NMRA Q2 Earnings? - Defense World

May 16, 2025
pulisher
May 16, 2025

William Blair Analysts Increase Earnings Estimates for NMRA - Defense World

May 16, 2025
pulisher
May 15, 2025

Neumora Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 15, 2025
pulisher
May 14, 2025

Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm - The Malaysian Reserve

May 14, 2025
pulisher
May 14, 2025

RBC Capital Sticks to Its Hold Rating for Neumora Therapeutics, Inc. (NMRA) - The Globe and Mail

May 14, 2025
pulisher
May 13, 2025

Neumora Therapeutics, Inc.: Strengthened Financial Position and Strategic Operational Enhancements Drive Buy Rating - TipRanks

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics Venture Debt Facility - Leerink Partners

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics (NMRA) Retains Buy Rating with Stable Price Target | NMRA Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Strategic Developments and Long-Term Growth Prospects for Neumora Therapeutics Amid Financial Stability Enhancements - TipRanks

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 13, 2025
pulisher
May 12, 2025

Earnings call transcript: Neumora Therapeutics Q1 2025 Sees Net Loss, Stock Rises - Investing.com

May 12, 2025
pulisher
May 12, 2025

Neumora Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Transcript : Neumora Therapeutics, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

May 12, 2025
pulisher
May 11, 2025

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely? - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025NMRA - ACCESS Newswire

May 11, 2025
pulisher
May 10, 2025

Neumora Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025NMRA - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Neumora Therapeutics (NMRA) Expected to Announce Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Neumora Therapeutics Inc (NASDAQ: NMRA): What Matters Now - Stocksregister

May 09, 2025
pulisher
May 09, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of "Hold" by Analysts - MarketBeat

May 09, 2025
pulisher
May 08, 2025

Schonfeld Strategic Advisors LLC Buys 381,676 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 08, 2025
pulisher
May 07, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of “Hold” by Analysts - Defense World

May 07, 2025
pulisher
May 06, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

May 06, 2025

Neumora Therapeutics Inc (NMRA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Neumora Therapeutics Inc (NMRA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BERNS PAUL L
See Remarks
Feb 18 '25
Sale
1.69
13,871
23,468
7,405,004
Milligan Michael Lee
See Remarks
Feb 18 '25
Sale
1.69
1,978
3,351
22,470
Aurora Daljit Singh
Chief Strategy Officer
Feb 18 '25
Sale
1.68
8,565
14,347
88,935
Lenz Robert A.
Head of R&D
Feb 18 '25
Sale
1.67
5,614
9,383
309,092
Pinto Joshua
President
Feb 18 '25
Sale
1.67
8,048
13,477
76,952
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):